These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23322154)

  • 1. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.
    Wang JR; Gramling SJ; Goldstein DP; Cheng D; Chen D; Azad AK; Tse A; Hon H; Chen Z; Mirshams M; Simpson C; Huang SH; Marquez S; O'Sullivan B; Liu FF; Roberts H; Xu W; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Reisman DN; Liu G
    Carcinogenesis; 2013 May; 34(5):1012-7. PubMed ID: 23322154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.
    Wong KM; Qiu X; Cheng D; Azad AK; Habbous S; Palepu P; Mirshams M; Patel D; Chen Z; Roberts H; Knox J; Marquez S; Wong R; Darling G; Waldron J; Goldstein D; Leighl N; Shepherd FA; Tsao M; Der S; Reisman D; Liu G
    Cancer Med; 2014 Apr; 3(2):426-33. PubMed ID: 24519853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.
    Liu G; Gramling S; Munoz D; Cheng D; Azad AK; Mirshams M; Chen Z; Xu W; Roberts H; Shepherd FA; Tsao MS; Reisman D
    Oncogene; 2011 Jul; 30(29):3295-304. PubMed ID: 21478907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome.
    Korpanty GJ; Eng L; Qiu X; Faluyi OO; Renouf DJ; Cheng D; Patel D; Chen Z; Tse BC; Knox JJ; Dodbiba L; Teichman J; Azad AK; Wong R; Darling G; Reisman D; Cuffe S; Liu G; Xu W
    Oncotarget; 2017 Apr; 8(17):28093-28100. PubMed ID: 28427211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
    Pasic I; Wong KM; Lee JJ; Espin-Garcia O; Brhane Y; Cheng D; Chen Z; Patel D; Brown C; Bucur R; Reisman D; Knox JJ; Xu W; Hung RJ; Liu G; Cleary SP
    Mol Carcinog; 2018 Jan; 57(1):106-113. PubMed ID: 28892201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cyclooxygenase-2 gene polymorphisms and head and neck squamous cell carcinoma risk.
    Niu Y; Yuan H; Shen M; Li H; Hu Y; Chen N
    J Craniofac Surg; 2014 Mar; 25(2):333-7. PubMed ID: 24469360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
    Liu G; Cuffe S; Liang S; Azad AK; Cheng L; Brhane Y; Qiu X; Cescon DW; Bruce J; Chen Z; Cheng D; Patel D; Tse BC; Laurie SA; Goss G; Leighl NB; Hung R; Bradbury PA; Seymour L; Shepherd FA; Tsao MS; Chen BE; Xu W; Reisman DN
    Clin Cancer Res; 2017 May; 23(10):2460-2470. PubMed ID: 27827316
    [No Abstract]   [Full Text] [Related]  

  • 8. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
    O-charoenrat P; Leksrisakul P; Sangruchi S
    Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.
    Hang D; Yin Y; Wang L; Yuan H; Du J; Zhu M; Dai J; Chen N; Hu Z; Shen H; Ma H
    J Oral Pathol Med; 2017 Sep; 46(8):598-602. PubMed ID: 27977878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
    Lee MJ; Kuehne N; Hueniken K; Liang S; Rai S; Sorotsky H; Herman M; Shepshelovich D; Bruce J; Liang M; Patel D; Cheng D; Chen Z; Eng L; Brown MC; Cho J; Leighl NB; de Perrot M; Reisman D; Xu W; Bradbury PA; Liu G
    Mol Carcinog; 2019 Nov; 58(11):1960-1973. PubMed ID: 31355511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
    Yu Y; Cheng D; Parfrey P; Liu G; Savas S
    PLoS One; 2018; 13(6):e0198873. PubMed ID: 29894502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRM polymorphisms, pancreatic cancer risk and survival.
    Segedi M; Anderson LN; Espin-Garcia O; Borgida A; Bianco T; Cheng D; Chen Z; Patel D; Brown MC; Xu W; Reisman D; Gallinger S; Cotterchio M; Hung R; Liu G; Cleary SP
    Int J Cancer; 2016 Dec; 139(11):2474-81. PubMed ID: 27487558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations.
    Gao X; Huang M; Liu L; He Y; Yu Q; Zhao H; Zhou C; Zhang J; Zhu Z; Wan J; Jiang X; Gao Y
    PLoS One; 2013; 8(1):e55169. PubMed ID: 23359823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising link of HLA-G polymorphism, tobacco consumption and risk of Head and Neck Squamous Cell Carcinoma (HNSCC) in North Indian population.
    Agnihotri V; Gupta A; Kumar R; Upadhyay AD; Dwivedi S; Kumar L; Dey S
    Hum Immunol; 2017 Feb; 78(2):172-178. PubMed ID: 28040535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.
    Choudhury JH; Ghosh SK
    J Oral Pathol Med; 2015 Aug; 44(7):495-501. PubMed ID: 25167831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRM promoter insertion polymorphisms increase the risk of cancer: A meta-analysis.
    Ouyang X; Ye XL; Wei HB
    Gene; 2017 Aug; 626():420-425. PubMed ID: 28571677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.